3rd Party Biotechnology Industry News

After a failed merger that led to massive layoffs and [...]

Roche is paying Dualitas Therapeutics $36.5 million upfront to screen [...]

North Immunology has decided its path to taking an atopic [...]

SK Biopharmaceuticals has added a second preclinical Parkinson’s disease therapy [...]

Novartis has extended its losing streak, stopping an amyotrophic lateral [...]

Novartis is paying Sironax $125 million to take up its [...]

Sling Therapeutics has closed a $123 million series C round [...]

Connect Biopharma’s hopes of dethroning Dupixent took a knock as [...]

Eli Lilly’s ongoing attempt to strengthen its genetic medicine offering [...]

Sionna Therapeutics is laying off almost half its workforce as [...]